You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Atenolol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for atenolol and what is the scope of patent protection?

Atenolol is the generic ingredient in five branded drugs marketed by Astrazeneca, Able, Apothecon, Aurobindo Pharma, Chartwell Rx, Hlthcare, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, SCS, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Twi Pharms, Unichem, Unique, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, Aurobindo Pharma Usa, Novitium Pharma, and Zydus Pharms, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for atenolol. Thirty-three suppliers are listed for this compound.

Drug Prices for atenolol

See drug prices for atenolol

Drug Sales Revenue Trends for atenolol

See drug sales revenues for atenolol

Recent Clinical Trials for atenolol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zagazig UniversityPhase 2
Ain Shams UniversityPhase 4
Columbia UniversityPhase 3

See all atenolol clinical trials

Pharmacology for atenolol

US Patents and Regulatory Information for atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva ATENOLOL atenolol TABLET;ORAL 074101-001 Jul 17, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 073665-001 Jul 2, 1992 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Northstar Hlthcare ATENOLOL atenolol TABLET;ORAL 078254-002 Sep 25, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 ⤷  Try a Trial ⤷  Try a Trial
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.